The key role of PCSK9 in the atherosclerotic process is also confirmed by a In Vivo experimental model conceived to obtain a quick and convenient model to study atherosclerosis in knockout or transgenic mice without having to generate double knockout on an ApoE−/− or LDLR−/− background [87]. Here, PCSK9 is linked to atherosclerosis.